Your browser doesn't support javascript.
loading
Use of Pralsetinib as Neoadjuvant Therapy for Non-Small Cell Lung Cancer Patient With RET Rearrangement.
Zhou, Ning; Li, Tong; Liang, Maoli; Ren, Fan; Ni, Hong; Liu, Wei; Shi, Tao; Xu, Dongbo; Chen, Qiusong; Yu, Haonan; Song, Zuoqing; Zu, Lingling; Li, Shuo; Xu, Song.
Affiliation
  • Zhou N; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Li T; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Liang M; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Ren F; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Ni H; Department of Respiratory and Critical Care, Tianjin Medical University General Hospital, Tianjin, China.
  • Liu W; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Shi T; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Xu D; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Chen Q; Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • Yu H; Department of Respiratory Medicine, Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Song Z; Precision Medicine Center, Tianjin Medical University General Hospital, Tianjin, China.
  • Zu L; Department of Pathology, Tianjin Medical University General Hospital, Tianjin, China.
  • Li S; Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, China.
  • Xu S; Department of PET/CT Diagnostic, Tianjin Medical University General Hospital, Tianjin, China.
Front Oncol ; 12: 848779, 2022.
Article in En | MEDLINE | ID: mdl-35223529
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: Country of publication: